Filter the drugs by their status, phase of research and how they help

COVID-19 is respiratory dissease caused by SARS-CoV-2 virus. Browse the database of drugs treating specific mutations compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
N14-R7 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/07/2020 Jul/08/2020 0
Remdesivir Emergency use authorization Experimental Antiviral Jul/07/2020 Jul/09/2020 0
sMVA vaccine Potential treatment - pre-clinical evidence Experimental Vaccine Jul/02/2020 Jul/03/2020 0
NCGC00411883-01 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/01/2020 Jul/03/2020 0
BNT162b1 Potential treatment - clinical evidence Experimental Vaccine Jul/01/2020 Jul/03/2020 0
NVX-CoV2373 Potential treatment - pre-clinical evidence Experimental Vaccine Jun/30/2020 Jul/03/2020 0
S1-Fc vaccine Potential treatment - pre-clinical evidence Experimental Vaccine Jun/30/2020 Jul/03/2020 0
MVA/S vaccine Potential treatment - pre-clinical evidence Experimental Vaccine Jun/27/2020 Jun/29/2020 0
Torin2 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/25/2020 Jun/26/2020 0
YM201636 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/25/2020 Jun/26/2020 0